NP2 Enkephalin For Treatment of Intractable Cancer Pain
Completed · Phase 2 · Has a placebo group
Conditions studied: Intractable Pain, Neoplasms
In brief
The purpose of this study is to examine the impact of intradermal delivery of NP2 on pain scores and pain medication usage in subjects with intractable pain due to malignant disease. A second purpose is to confirm safety and secondary efficacy measurements.
Key facts
- Study ID
- NCT01291901
- Run by
- Diamyd Inc
- People needed
- 33
- Starts
- 2011-01-01
- Expected to finish
- 2013-11-01
- Last updated by the study team
- 2014-08-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- HOPE Research Institute — Phoenix, Arizona, United States
- Arizona Clinical Research Center — Tucson, Arizona, United States
- Compassionate Cancer Care Medical Group, Inc. — Corona, California, United States
- Cancer Care Associates — Fresno, California, United States
- TriWest Research Associates — La Mesa, California, United States
- White Memorial Medical Center — Los Angeles, California, United States
- Hematology Oncology Associates — Oakland, California, United States
- Advanced Pharma CR — Miami, Florida, United States
- Better Health Clinical Research Inc — Newnan, Georgia, United States
- Christie Clinic — Champaign, Illinois, United States
- Global Scientific Innovations — Evansville, Indiana, United States
- Montana Cancer Institute Foundation — Missoula, Montana, United States
- Center for Clinical Research — Winston-Salem, North Carolina, United States
- Signal Point Clinical research Center — Middletown, Ohio, United States
- Pain Research of Oregon — Eugene, Oregon, United States
- Hematology Oncology Associatesof Rhode Island — Cranston, Rhode Island, United States
- Medical Therapy and Research — San Antonio, Texas, United States
- Medical Oncology Associates — Spokane, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.